Genetische Untersuchungen beim Parkinson-Syndrom: Indikation und praktische Durchführung

Lars Tönges; Chi Wang Ip; Christian Dresel; Paul Lingor; Ilona Csoti; Zacharias Kohl; Jürgen Winkler; Stephan Klebe

doi:10.1055/a-1155-6389

Genetische Untersuchungen beim Parkinson-Syndrom: Indikation und praktische Durchführung

Translated title of the contribution: Genetic testing for Parkinson's disease: Indication and practical implementation

Lars Tönges, Chi Wang Ip, Christian Dresel, Paul Lingor, Ilona Csoti, Zacharias Kohl, Jürgen Winkler, Stephan Klebe

Research output: Contribution to journal › Article › peer-review

Abstract

More than 20 years have passed since the first description of a monogenic cause of Parkinson's disease. Despite the tremendous advances of genetic testing these techniques are rarely used in Parkinson's disease. However, genetic tests in patients with Parkinson's syndrome will play an important role in the future. This is not only to ensure the diagnosis of Parkinson's patients with a young onset and / or a positive family history, but also in the context of personalised medicine with new therapeutic options. In the following we would like to give an overview of the basics of genetic testing, the legal requirements, the procedure for genetic testing and an outlook into the future for hereditary Parkinson's diseases.

Translated title of the contribution	Genetic testing for Parkinson's disease: Indication and practical implementation
Original language	German
Pages (from-to)	601-608
Number of pages	8
Journal	Fortschritte der Neurologie Psychiatrie
Volume	88
Issue number	9
DOIs	https://doi.org/10.1055/a-1155-6389
State	Published - 1 Sep 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1055/a-1155-6389

Cite this

@article{8d9f7819f2794547a63537d2b488719d,

title = "Genetische Untersuchungen beim Parkinson-Syndrom: Indikation und praktische Durchf{\"u}hrung",

abstract = "More than 20 years have passed since the first description of a monogenic cause of Parkinson's disease. Despite the tremendous advances of genetic testing these techniques are rarely used in Parkinson's disease. However, genetic tests in patients with Parkinson's syndrome will play an important role in the future. This is not only to ensure the diagnosis of Parkinson's patients with a young onset and / or a positive family history, but also in the context of personalised medicine with new therapeutic options. In the following we would like to give an overview of the basics of genetic testing, the legal requirements, the procedure for genetic testing and an outlook into the future for hereditary Parkinson's diseases.",

keywords = "Genetic testing, Genetics, Parkinson's disease",

author = "Lars T{\"o}nges and Ip, {Chi Wang} and Christian Dresel and Paul Lingor and Ilona Csoti and Zacharias Kohl and J{\"u}rgen Winkler and Stephan Klebe",

year = "2020",

month = sep,

day = "1",

doi = "10.1055/a-1155-6389",

language = "Deutsch",

volume = "88",

pages = "601--608",

journal = "Fortschritte der Neurologie Psychiatrie",

issn = "0720-4299",

publisher = "Georg Thieme Verlag",

number = "9",

}

TY - JOUR

T1 - Genetische Untersuchungen beim Parkinson-Syndrom

T2 - Indikation und praktische Durchführung

AU - Tönges, Lars

AU - Ip, Chi Wang

AU - Dresel, Christian

AU - Lingor, Paul

AU - Csoti, Ilona

AU - Kohl, Zacharias

AU - Winkler, Jürgen

AU - Klebe, Stephan

PY - 2020/9/1

Y1 - 2020/9/1

N2 - More than 20 years have passed since the first description of a monogenic cause of Parkinson's disease. Despite the tremendous advances of genetic testing these techniques are rarely used in Parkinson's disease. However, genetic tests in patients with Parkinson's syndrome will play an important role in the future. This is not only to ensure the diagnosis of Parkinson's patients with a young onset and / or a positive family history, but also in the context of personalised medicine with new therapeutic options. In the following we would like to give an overview of the basics of genetic testing, the legal requirements, the procedure for genetic testing and an outlook into the future for hereditary Parkinson's diseases.

AB - More than 20 years have passed since the first description of a monogenic cause of Parkinson's disease. Despite the tremendous advances of genetic testing these techniques are rarely used in Parkinson's disease. However, genetic tests in patients with Parkinson's syndrome will play an important role in the future. This is not only to ensure the diagnosis of Parkinson's patients with a young onset and / or a positive family history, but also in the context of personalised medicine with new therapeutic options. In the following we would like to give an overview of the basics of genetic testing, the legal requirements, the procedure for genetic testing and an outlook into the future for hereditary Parkinson's diseases.

KW - Genetic testing

KW - Genetics

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=85090214078&partnerID=8YFLogxK

U2 - 10.1055/a-1155-6389

DO - 10.1055/a-1155-6389

M3 - Artikel

C2 - 32594506

AN - SCOPUS:85090214078

SN - 0720-4299

VL - 88

SP - 601

EP - 608

JO - Fortschritte der Neurologie Psychiatrie

JF - Fortschritte der Neurologie Psychiatrie

IS - 9

ER -

Genetische Untersuchungen beim Parkinson-Syndrom: Indikation und praktische Durchführung

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this